The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Methodology of the SORENTO clinical trial: Assessing the efficacy and safety of high exposure octreotide subcutaneous depot in patients with GEP-NETs.
 
Simron Singh
Employment - Sanofi (I)
Honoraria - Advanced Accelerator Applications/Novartis; IPSEN
Research Funding - Novartis (Inst)
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Jennifer A. Chan
Stock and Other Ownership Interests - Merck
Honoraria - Advanced Accelerator Applications; Ipsen
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer (I); Pfizer (I); TerSera
Research Funding - Lilly (Inst); Sanofi (Inst)
(OPTIONAL) Uncompensated Relationships - Camurus
 
Wouter de Herder
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Camurus; Ipsen
Speakers' Bureau - Advanced Accelerator Applications/Novartis; Ipsen
Research Funding - Advanced Accelerator Applications/Novartis (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Diego Ferone
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Camurus; Ipsen; Recordati
Research Funding - Advanced Accelerator Applications/Novartis (Inst); Bristol-Myers Squibb (Inst); Recordati (Inst)
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Ipsen; Pfizer
 
Daniel M. Halperin
Consulting or Advisory Role - Advanced Accelerator Applications; Camurus; Chimeric Therapeutics; Crinetics Pharmaceuticals; Curium Pharma; Ipsen; Isotopen Technologien; Lexicon; Novartis; Progenics; Radiomedix; Tersera
Research Funding - Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Isotopen Technologien (Inst); Tarveda Therapeutics (Inst); Thermo Fisher Scientific (Inst)
 
Josh Mailman
Stock and Other Ownership Interests - Abbott Laboratories; Anthem; AstraZeneca; DANAHER; Dexcom; LabCorp; Medtronic; Novo Nordisk; Sanofi; Thermo Fisher Scientific; Veeva Systems
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Camurus; Crinetics Pharmaceuticals; ITM Oncologics; RayzeBio
 
Mozhgan Dorkhan
Employment - Camurus
Leadership - Vibrosense Dynamics
Stock and Other Ownership Interests - Amarin Corporation; Oncopeptides; Pharmiva; Vibrosense Dynamics
 
Lisa Hellström
Employment - Camurus
 
Agneta Svedberg
Employment - Camurus
Leadership - Camurus
Stock and Other Ownership Interests - Camurus; Cantargia AB; Genmab; Zealand Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Cantargia AB
 
Fredrik Tiberg
Employment - Camurus
Leadership - Camurus
Stock and Other Ownership Interests - Camurus
Research Funding - Camurus
Patents, Royalties, Other Intellectual Property - Camurus